Literature DB >> 7513788

How variable is a spontaneous mutation rate in cultured mammalian cells?

J J Boesen1, M J Niericker, N Dieteren, J W Simons.   

Abstract

The Luria-Delbrück fluctuation analysis provides a method to estimate mutation rates and is commonly applied in somatic cell genetics and in cancer biology. We developed an assay for a Luria-Delbrück fluctuation analysis using the mouse lymphoma cell line, GRSL13. As these cells grow in suspension, one can handle hundreds of parallel cultures using multiwell dishes and dispensers. This assay thereby allows not only an accurate determination of the mutation rate per cell generation but also makes it possible to determine at which time after seeding mutations take place. Using approx. 8000 parallel cultures it has been possible to test whether the mutation rate is constant during the assay. It has been found that the spontaneous mutation rate of GRSL13 cells decreases in the course of a fluctuation test from 2 x 10(-6) to about 2 x 10(-7)/cell/generation. It was shown that this increased replication fidelity may partly be caused by cell density: maintenance of cells at high cell density resulted in a spontaneous mutation rate of 0.7 +/- 4.0 x 10(-7) compared to 4.0 +/- 3.1 x 10(-7) for the standard protocol. In contrast, growing the cells at extremely low cell density resulted in an enhanced mutation rate of 7.7 +/- 1.3 x 10(-7). Thus altogether the mutation rate can vary from 2 x 10(-6) to 0.7 x 10(-7) (approx. 30-fold). These results show that the spontaneous mutation rate is not constant, but highly dependent on experimental conditions. As incomplete expression and metabolic cooperation cannot explain the findings, the data suggest that the fidelity of DNA replication is not fixed but open to variation. Hence, determination of replication infidelity in cultured cells needs rigorous standardization or/and application of controlled variation in culture conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513788     DOI: 10.1016/0027-5107(94)90284-4

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

1.  Clonal aspects of plant cell proliferation and their applications to animal cells and bacteria.

Authors:  R W Korn
Journal:  Cell Prolif       Date:  2008-04-23       Impact factor: 6.831

Review 2.  Hypermutability in carcinogenesis.

Authors:  B S Strauss
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

3.  Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate.

Authors:  Jim Werngren; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Human ABCG2: structure, function, and its role in multidrug resistance.

Authors:  Wei Mo; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2011-03-30

5.  Variability in APOE genotype status in human-derived cell lines: a cause for concern in cell culture studies?

Authors:  Sebastian Schaffer; Vanessa Y M Lam; Insa M A Ernst; Patricia Huebbe; Gerald Rimbach; Barry Halliwell
Journal:  Genes Nutr       Date:  2013-12-03       Impact factor: 5.523

6.  MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.

Authors:  G K Chen; G E Durán; A Mangili; L Beketic-Oreskovic; B I Sikic
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

7.  Improved sequence variant analysis strategy by automated false positive removal.

Authors:  Wenzhou Li; Jette Wypych; Robert J Duff
Journal:  MAbs       Date:  2017-06-07       Impact factor: 5.857

8.  No excessive mutations in transcription activator-like effector nuclease-mediated α-1,3-galactosyltransferase knockout Yucatan miniature pigs.

Authors:  Kimyung Choi; Joohyun Shim; Nayoung Ko; Joonghoon Park
Journal:  Asian-Australas J Anim Sci       Date:  2019-08-23       Impact factor: 2.509

9.  Experimental design to evaluate directed adaptive mutation in Mammalian cells.

Authors:  Michael Bordonaro; Christopher R Chiaro; Tobias May
Journal:  JMIR Res Protoc       Date:  2014-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.